Kj. Escott et al., THE MODULATION OF THE INCREASE IN RAT FACIAL SKIN BLOOD-FLOW OBSERVEDAFTER TRIGEMINAL GANGLION STIMULATION, European journal of pharmacology, 284(1-2), 1995, pp. 69-76
Electrical stimulation of the trigeminal ganglion causes an increase i
n facial skin blood flow in the anaesthetised rat, as measured by lase
r Doppler flowmetry. We investigated the modulation of this neurogenic
vasodilator response using selective receptor agonists for putative p
rejunctional inhibitory receptors, as well as other pharmacological ag
ents to further characterise this response. [D-Ala(2),Me-Phe(4),Gly(5)
-ol]enkephalin (DAGO, a mu-opioid receptor agonist) inhibited the vaso
dilator response in a dose-related (0.058-5.8 mu mol/kg i.v.) and nalo
xone-sensitive manner. A similar inhibitory response was observed with
the local anaesthetic lignocaine (2% w/v, s.c. 20 mu l) In contrast,
the histamine H-3-receptor agonist mu-methylhistamine (15 or 35 mu mol
/kg, i.v.) and the 5-HT1D receptor agonists sumatriptan (0.24 or 2.4 m
u mol/kg, i.v.) and CP 122,288 (0.0003-3 mu mol/kg, i.v.) had no effec
t on these responses. Similarly, atropine (1.5 mu mol/kg, i.v.) and in
domethacin (28 mu mol/kg, i.v.) did not alter the vasodilatation obser
ved in this model. In conclusion, only mu-opioid receptor activation a
nd local anaesthetic had any inhibitory action on the neurogenic vasod
ilatation observed in this model.